免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

PubMed

Bridging Early Feasibility and Pivotal Trials: Insights From Transcatheter Tricuspid Valve Interventions.

PMID:42624759 ·

M, o, n, i, c, a, , T, o, c, c, h, i, ;, , E, l, e, o, n, o, r, a, , C, a, p, u, z, z, i, ;, , C, a, r, o, l, i, n, a, , M, a, t, s, u, b, a, y, a, s, h, i, ;, , V, a, l, e, r, i, e, , T, s, e, n, g, -, R, o, g, l, e, r, ;, , V, i, v, i, e, n, n, e, , K, a, y, s, e, r, -, S, o, l, t, y, s, ;, , D, a, r, y, a, , G, h, o, l, a, m, i, ;, , M, a, d, e, l, e, i, n, e, , B, l, a, n, k, e, n, s, p, o, o, r, ;, , N, a, z, i, a, , E, j, a, z, ;, , S, i, l, v, i, a, , R, u, g, g, i, e, r, i, ;, , D, a, v, i, d, e, , D, e, c, a, n, d, i, a, ;, , E, r, i, k, , A, l, v, a, r, a, d, o, ;, , B, r, a, n, d, o, n, , W, i, l, l, i, a, m, s, ;, , M, o, h, a, m, m, e, d, , A, d, i, n, a, n, ;, , P, a, o, l, a, , A, n, t, o, n, i, n, i, ;, , G, i, u, d, i, t, t, a, , C, a, l, l, e, a, ;, , H, e, l, e, n, , B, a, n, k, s

期刊Clinical therapeutics
年份
PMID42624759

摘要

Early feasibility studies (EFS) are critical in the clinical development of high-risk cardiovascular devices, enabling first-in-human evaluation and iterative refinement prior to pivotal investigation. Regulatory frameworks supporting EFS have evolved substantially in the United States (US), while structured European pathways are emerging. This narrative review evaluates the evolution of the US EFS framework and examines its alignment with emerging European initiatives, using transcatheter tricu

官方来源

在 PubMed 上查看 →

数据来自 PubMed / NCBI。有关全文和最新信息,请始终参阅官方记录。

↑